ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Policy

Research Tax Credit Backed By House

by Glenn Hess
May 25, 2015 | APPEARED IN VOLUME 93, ISSUE 21

The House of Representatives approved legislation (H.R. 880) last week that would permanently reauthorize the now temporary R&D tax credit. The bill would make the credit a permanent part of the tax code, retroactive to Dec. 31, 2014, when it expired. The measure would also increase the value of the credit from 14% to 20% of qualified R&D expenses. Since the research incentive’s inception in 1981, Congress has repeatedly extended it for one or two years, often retroactively. But according to chemical manufacturers, drugmakers, and other industries, the resulting uncertainty has made it difficult to effectively plan and conduct R&D projects. The White House opposes H.R. 880, arguing it would increase the federal deficit by $182 billion over a decade because the bill’s sponsors have no plan to offset the tax revenue that would be lost.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment